News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
207 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (24222)
Month
January (2882)
February (2030)
March (1769)
April (2200)
May (2664)
June (3161)
July (3087)
August (3800)
September (4259)
October (5135)
November (4629)
December (3503)
Day
1 (3)
2 (126)
3 (109)
4 (46)
5 (53)
6 (70)
7 (2)
8 (3)
9 (93)
10 (97)
11 (67)
12 (115)
13 (23)
16 (45)
17 (61)
18 (207)
19 (143)
20 (33)
21 (1)
22 (1)
23 (48)
24 (107)
25 (87)
26 (242)
27 (149)
29 (6)
30 (263)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
16
17
18
19
20
21
22
23
24
25
26
27
29
30
Drug Development
Evotec and Bayer Advance Third Endometriosis Programme into Phase I Clinical Development
Milestone achieved under the highly successful strategic alliance Evotec and Bayer entered in October 2012.
April 18, 2018
·
4 min read
Drug Development
Sosei Confirms New Data Demonstrating AZD4635, a Novel A2A Receptor Antagonist, Induces Anti-Tumor Immunity Alone and in Combination With Anti-PD-L1 in Preclinical Models
New data presented at 2018 AACR Meeting
April 18, 2018
·
4 min read
FDA
NeuroVive’s KL1333 Receives FDA Orphan Drug Designation for Treatment of Mitochondrial Diseases
Orphan drug designation will give the KL1333 program extra access to regulatory and scientific advice and interactions at the FDA
April 18, 2018
·
4 min read
Business
UNMC, GenomOncology combine to launch first system using HL7 2.5 formatting to transmit discrete genetic data on cancer patients to electronic health record
Breakthrough addresses huge problem in management of health information; will advance ability of health professionals to practice precision medicine and ensure patients receive right treatment at right time.
April 18, 2018
·
5 min read
Business
Fusion Pharmaceuticals Licenses Isogenica’s CIS Display Technology
Technology will be used to progress Fusion’s pipeline of alpha therapeutics for the treatment of cancers
April 18, 2018
·
1 min read
Drug Development
InteRNA Demonstrates Preclinical Proof-of-Concept for Lead microRNA Candidate INT-1B3 in a Range of Cancer Models at 2018 AACR Annual Meeting
INT-1B3 targets multiple hallmarks of cancer as a single agent resulting in immune-system activation, tumor regression and pronounced long term immunity
April 18, 2018
·
4 min read
Business
Sempre Health and Novo Nordisk Partner to Improve Medication Costs for Patients With Diabetes
Sempre works with health plans to reward their membership’s positive choices and actions.
April 18, 2018
·
2 min read
BioCapital
Institute of Human Virology (IHV) Will Undertake Largest HIV Survey Ever Conducted in a Single Country
$100 Million Project Will Enable Researchers to Better Understand HIV in Nigeria
April 18, 2018
·
4 min read
Business
NAMSAP Says CMS’s MSA Policy Institutionalizes Opioid Abuse
The Medicare Set-Aside program of the Centers for Medicare and Medicaid Services “encourages, intensifies and effectively orders long-term opioid use and abuse by Medicare beneficiaries,” according to the National Alliance of Medicare Set-Aside Professionals.
April 18, 2018
·
1 min read
BioMidwest
Kraig Biocraft Laboratories Releases a Statement Regarding Spider Silk Industry
As the Company prepares for commercialization of its engineered spider silk, Kraig Labs shares information on the developing industry.
April 18, 2018
·
6 min read
1 of 21
Next